AAAAAA

   
Results: 1-9 |
Results: 9
CPG MOTIFS AS IMMUNE ADJUVANTS
Authors: KLINMAN DM BARNHART KM CONOVER J
Citation: Dm. Klinman et al., CPG MOTIFS AS IMMUNE ADJUVANTS, Vaccine, 17(1), 1999, pp. 19-25
ENHANCER AND PROMOTER CHIMERAS IN PLASMIDS DESIGNED FOR INTRAMUSCULARINJECTION - A COMPARATIVE IN-VIVO AND IN-VITRO STUDY
Authors: BARNHART KM HARTIKKA J MANTHORPE M NORMAN J HOBART P
Citation: Km. Barnhart et al., ENHANCER AND PROMOTER CHIMERAS IN PLASMIDS DESIGNED FOR INTRAMUSCULARINJECTION - A COMPARATIVE IN-VIVO AND IN-VITRO STUDY, Human gene therapy, 9(17), 1998, pp. 2545-2553
IMMUNOTHERAPY OF ESTABLISHED TUMORS IN MICE BY INTRATUMORAL INJECTIONOF INTERLEUKIN-2 PLASMID DNA - INDUCTION OF CD8(-CELL IMMUNITY() T)
Authors: SAFFRAN DC HORTON HM YANKAUCKAS MA ANDERSON D BARNHART KM ABAI AM HOBART P MANTHORPE M NORMAN JA PARKER SE
Citation: Dc. Saffran et al., IMMUNOTHERAPY OF ESTABLISHED TUMORS IN MICE BY INTRATUMORAL INJECTIONOF INTERLEUKIN-2 PLASMID DNA - INDUCTION OF CD8(-CELL IMMUNITY() T), Cancer gene therapy, 5(5), 1998, pp. 321-330
LIPID-MEDIATED AND ADENOVIRAL-MEDIATED GENE-TRANSFER INTO AIDS KAPOSIS-SARCOMA CELL-LINES
Authors: CAMPAIN JA MATASSA AK FELGNER PL BARNHART KM CURIEL DT HARRISON GS
Citation: Ja. Campain et al., LIPID-MEDIATED AND ADENOVIRAL-MEDIATED GENE-TRANSFER INTO AIDS KAPOSIS-SARCOMA CELL-LINES, Cancer gene therapy, 5(3), 1998, pp. 131-143
SYSTEMIC DELIVERY OF PROINSULIN FOLLOWING INJECTION OF PLASMID DNA TOSKELETAL-MUSCLE INDICATES POTENTIAL FOR GENE THERAPEUTIC TREATMENT OFIDDM
Authors: MABAI A BARNHART KM HOBART PM NORMAN JA
Citation: A. Mabai et al., SYSTEMIC DELIVERY OF PROINSULIN FOLLOWING INJECTION OF PLASMID DNA TOSKELETAL-MUSCLE INDICATES POTENTIAL FOR GENE THERAPEUTIC TREATMENT OFIDDM, Diabetes, 46, 1997, pp. 290-290
MATRIX ATTACHMENT REGIONS AS TRANSCRIPTION ENHANCING ELEMENTS IN PLASMIDS DESIGNED FOR IN-VIVO HUMAN GENE-THERAPY
Authors: BARNHART KM LIANG XW HARTIKKA J HOBART P
Citation: Km. Barnhart et al., MATRIX ATTACHMENT REGIONS AS TRANSCRIPTION ENHANCING ELEMENTS IN PLASMIDS DESIGNED FOR IN-VIVO HUMAN GENE-THERAPY, Journal of cellular biochemistry, 1995, pp. 128-128
THE ORPHAN NUCLEAR RECEPTOR, STEROIDOGENIC FACTOR-I, REGULATES THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE IN PITUITARY GONADOTROPES
Authors: BARNHART KM MELLON PL
Citation: Km. Barnhart et Pl. Mellon, THE ORPHAN NUCLEAR RECEPTOR, STEROIDOGENIC FACTOR-I, REGULATES THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE IN PITUITARY GONADOTROPES, Molecular endocrinology, 8(7), 1994, pp. 878-885
THE SEQUENCE OF A MURINE CDNA-ENCODING EAR-2, A NUCLEAR ORPHAN RECEPTOR
Authors: BARNHART KM MELLON PL
Citation: Km. Barnhart et Pl. Mellon, THE SEQUENCE OF A MURINE CDNA-ENCODING EAR-2, A NUCLEAR ORPHAN RECEPTOR, Gene, 142(2), 1994, pp. 313-314
HELIX-LOOP-HELIX PROTEINS ARE PRESENT AND DIFFERENTIALLY EXPRESSED INDIFFERENT CELL-LINES FROM THE ANTERIOR-PITUITARY
Authors: JACKSON SM BARNHART KM MELLON PL GUTIERREZHARTMANN A HOEFFLER JP
Citation: Sm. Jackson et al., HELIX-LOOP-HELIX PROTEINS ARE PRESENT AND DIFFERENTIALLY EXPRESSED INDIFFERENT CELL-LINES FROM THE ANTERIOR-PITUITARY, Molecular and cellular endocrinology, 96(1-2), 1993, pp. 167-176
Risultati: 1-9 |